|
Name |
Cinerolon
|
Molecular Formula | C10H14O2 | |
IUPAC Name* |
2-[(Z)-but-2-enyl]-4-hydroxy-3-methylcyclopent-2-en-1-one
|
|
SMILES |
C/C=C\CC1=C(C(CC1=O)O)C
|
|
InChI |
InChI=1S/C10H14O2/c1-3-4-5-8-7(2)9(11)6-10(8)12/h3-4,9,11H,5-6H2,1-2H3/b4-3-
|
|
InChIKey |
YLKLJBPHNWWPSF-ARJAWSKDSA-N
|
|
Synonyms |
Cinerolon; Cinerolone; 17190-74-8; 2-[(Z)-but-2-enyl]-4-hydroxy-3-methylcyclopent-2-en-1-one; 2-Cyclopenten-1-one, 2-(2-butenyl)-4-hydroxy-3-methyl-, (Z)-; Z-Cinerolone; 2-[(Z)-BUT-2-ENYL]-4-HYDROXY-3-METHYL-CYCLOPENT-2-EN-1-ONE; cis -Cinerolone; SCHEMBL10631200; 2-[(2Z)-2-Butenyl]-4-hydroxy-3-methyl-2-cyclopenten-1-one; 2-Cyclopenten-1-one, 2-(2Z)-2-buten-1-yl-4-hydroxy-3-methyl-
|
|
CAS | 17190-74-8 | |
PubChem CID | 5374041 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 166.22 | ALogp: | 0.7 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 37.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 12 | QED Weighted: | 0.638 |
Caco-2 Permeability: | -4.351 | MDCK Permeability: | 0.00002480 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.906 | Plasma Protein Binding (PPB): | 32.99% |
Volume Distribution (VD): | 0.82 | Fu: | 65.86% |
CYP1A2-inhibitor: | 0.031 | CYP1A2-substrate: | 0.412 |
CYP2C19-inhibitor: | 0.032 | CYP2C19-substrate: | 0.739 |
CYP2C9-inhibitor: | 0.011 | CYP2C9-substrate: | 0.652 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.337 |
CYP3A4-inhibitor: | 0.038 | CYP3A4-substrate: | 0.274 |
Clearance (CL): | 15.601 | Half-life (T1/2): | 0.901 |
hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.114 |
Drug-inuced Liver Injury (DILI): | 0.567 | AMES Toxicity: | 0.041 |
Rat Oral Acute Toxicity: | 0.206 | Maximum Recommended Daily Dose: | 0.036 |
Skin Sensitization: | 0.69 | Carcinogencity: | 0.597 |
Eye Corrosion: | 0.949 | Eye Irritation: | 0.969 |
Respiratory Toxicity: | 0.727 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001459 | 0.354 | D0H6VY | 0.193 | ||||
ENC003622 | 0.341 | D06XWB | 0.188 | ||||
ENC005957 | 0.321 | D0N0OU | 0.184 | ||||
ENC005292 | 0.316 | D0CL9S | 0.182 | ||||
ENC001840 | 0.300 | D0T3NY | 0.177 | ||||
ENC005984 | 0.288 | D0Z4BV | 0.173 | ||||
ENC002343 | 0.273 | D0R2KF | 0.169 | ||||
ENC002751 | 0.269 | D0X7JN | 0.167 | ||||
ENC004982 | 0.267 | D0S5CH | 0.167 | ||||
ENC004404 | 0.267 | D04VIS | 0.163 |